Metformin Use Is Associated with Reduced Risk of Heart Failure Events in Patients with Diabetes

被引：0
作者：
Lanfear, David [1 ]
Velez, Mauricio [1 ]
Peterson, Edward [1 ]
Wells, Karen [1 ]
Sabbah, Hani N. [1 ]
Williams, L. Keoki [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2013年 / 19卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2013.06.102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
084
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [21] Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
    Jan Benes
    Martin Kotrc
    Katerina Kroupova
    Peter Wohlfahrt
    Jan Kovar
    Janka Franekova
    Marketa Hegarova
    Lenka Hoskova
    Eva Hoskova
    Terezie Pelikanova
    Petr Jarolim
    Josef Kautzner
    Vojtech Melenovsky
    Scientific Reports, 12
  • [22] Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
    Benes, Jan
    Kotrc, Martin
    Kroupova, Katerina
    Wohlfahrt, Peter
    Kovar, Jan
    Franekova, Janka
    Hegarova, Marketa
    Hoskova, Lenka
    Hoskova, Eva
    Pelikanova, Terezie
    Jarolim, Petr
    Kautzner, Josef
    Melenovsky, Vojtech
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
    Berstein, Lev M.
    Boyarkina, Marina P.
    Teslenko, Svetlana Yu.
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1308 - 1313
  • [24] Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
    Lev M. Berstein
    Marina P. Boyarkina
    Svetlana Yu. Teslenko
    Medical Oncology, 2012, 29 : 1308 - 1313
  • [25] Riluzole is associated with reduced risk of heart failure
    Kim, Kibum
    Kim, Sodam
    Katana, Margaret
    Terentyev, Dmitry
    Radwanski, Przemyslaw B.
    Munger, Mark A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
  • [26] Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
    Erkens, JA
    Klungel, OH
    Herings, RMC
    Stolk, RP
    Spoelstra, JA
    Grobbee, DE
    Leufkens, HGM
    EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1575 - 1579
  • [27] Metformin and thiazolidinedione use in medicare patients with heart failure
    Masoudi, FA
    Wang, YF
    Inzucchi, SE
    Setaro, JF
    Havranek, EP
    Foody, JM
    Krumholz, HM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01): : 81 - 85
  • [28] Metformin use is associated with reduced mortality risk in diabetic patients with Parkinson's disease
    Pezzoli, Gianni
    Cereda, Emanuele
    Calandrella, Daniela
    Barichella, Michela
    Bonvegna, Salvatore
    Isaias, Ioannis U.
    CLINICAL NUTRITION ESPEN, 2024, 60 : 309 - 312
  • [29] Is metformin beneficial for heart failure in patients with type 2 diabetes?
    Packer, Milton
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 136 : 168 - 170
  • [30] Contraindicated metformin fares well in heart failure patients with diabetes
    不详
    FORMULARY, 2005, 40 (12) : 428 - 428
12345